ALPS Advisors’s Atara Biotherapeutics ATRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,827	Closed	-$889K	–	1035
2022 Q1	$889K	Sell	3,827 -266	-6%	-$84.7K	0.01%	322
2021 Q4	$1.61M	Sell	4,093 -62	-1%	-$26.1K	0.02%	309
2021 Q3	$1.86M	Sell	4,155 -274	-6%	-$98.2K	0.02%	327
2021 Q2	$1.72M	Buy	+4,429	New	+$1.58M	0.02%	345
2019 Q2	–	Sell	-4,410	Closed	-$4.38M	–	881
2019 Q1	$4.38M	Buy	4,410 +190	+5%	+$177K	0.03%	178
2018 Q4	$3.67M	Buy	4,220 +1,010	+31%	+$938K	0.03%	179
2018 Q3	$3.32M	Buy	3,210 +677	+27%	+$662K	0.02%	196
2018 Q2	$2.33M	Buy	2,533 +286	+13%	+$307K	0.02%	217
2018 Q1	$2.19M	Buy	2,247 +891	+66%	+$812K	0.02%	207
2017 Q4	$614K	Buy	1,356 +152	+13%	+$56.1K	﹤0.01%	382
2017 Q3	$498K	Buy	1,204 +153	+15%	+$57.7K	﹤0.01%	523
2017 Q2	$368K	Buy	1,051 +58	+6%	+$22.3K	﹤0.01%	697
2017 Q1	$510K	Sell	993 -116	-10%	-$48K	﹤0.01%	391
2016 Q4	$394K	Sell	1,109 -360	-25%	-$152K	﹤0.01%	602
2016 Q3	$786K	Buy	+1,469	New	+$798K	0.01%	233
2016 Q1	–	Sell	-1,509	Closed	-$996K	–	649
2015 Q4	$996K	Sell	1,509 -265	-15%	-$200K	0.01%	218
2015 Q3	$13.9K	Buy	1,774 +808	+84%	+$985K	0.01%	192
2015 Q2	$1.27M	Buy	+966	New	+$1.11M	0.01%	196

Other funds holding ATRA